• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国急性ST段抬高或非ST段抬高型心肌梗死注册研究(FAST-MI):研究设计与基线特征

The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.

作者信息

Cambou J-P, Simon T, Mulak G, Bataille V, Danchin N

机构信息

Société française de cardiologie, 5 rue des Colonnes du Trône, 75012 Paris.

出版信息

Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):524-34.

PMID:17893635
Abstract

The FAST MI registry was designed to evaluate the 'real world' management of patients with acute myocardial infarction (MI), and to assess their in-hospital, medium- and long-term outcomes. Patients were recruited consecutively from intensive care units over a period of one month (from October 2005), with an additional one-month recruitment period for diabetic patients. The study included 3059 MI patients in phase 1 and an additional 611 diabetic patients in phase 2. Altogether, 53% of the patients had a final diagnosis of Q wave MI and 47% had non Q wave MI. Patients with Q wave MI were more likely to be men, younger, more frequently with a family history or a history of smoking. Patients with non Q wave MI had worst baseline demographic and clinical characteristics mainly explained by their older age. Time from symptom onset to hospital admission was less than three hours for 22% of the patients with Q wave MI and for 14% of the non Q wave MI patients. Among patients with Q wave MI, 64% received reperfusion therapy, 35% with primary percutaneous coronary interventions, 19% with pre-hospital thrombolysis and 10% with in-hospital thrombolysis. Over 70% of patients received statin therapy during the hospital stay and over 90% anti platelet agents. In-hospital mortality was 5.8% in patients with Q wave MI and 4.9% in patients with non Q Wave MI. At discharge beta-adrenergic blockers and statins and, to a lesser extent, medications of the renin angiotensin system were commonly prescribed. Over 90% received antiplatelet agents.

摘要

快速心肌梗死(MI)注册研究旨在评估急性心肌梗死患者的“真实世界”管理情况,并评估他们的住院、中长期结局。在一个月的时间里(从2005年10月开始),从重症监护病房连续招募患者,糖尿病患者另有一个月的招募期。该研究第一阶段纳入了3059例MI患者,第二阶段又纳入了611例糖尿病患者。总体而言,53%的患者最终诊断为Q波MI,47%为非Q波MI。Q波MI患者更可能为男性、更年轻,更频繁地有家族史或吸烟史。非Q波MI患者的基线人口统计学和临床特征最差,主要原因是他们年龄较大。Q波MI患者中22%、非Q波MI患者中14%从症状发作到入院的时间少于3小时。在Q波MI患者中,64%接受了再灌注治疗,35%接受了直接经皮冠状动脉介入治疗,19%接受了院前溶栓治疗,10%接受了院内溶栓治疗。超过70%的患者在住院期间接受了他汀类药物治疗,超过90%接受了抗血小板药物治疗。Q波MI患者的住院死亡率为5.8%,非Q波MI患者为4.9%。出院时,β受体阻滞剂和他汀类药物以及在较小程度上肾素血管紧张素系统药物通常被处方。超过90%的患者接受了抗血小板药物治疗。

相似文献

1
The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.法国急性ST段抬高或非ST段抬高型心肌梗死注册研究(FAST-MI):研究设计与基线特征
Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):524-34.
2
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.院前溶栓治疗对急性心肌梗死1年预后的影响:来自法国全国性USIC 2000注册研究的结果
Circulation. 2004 Oct 5;110(14):1909-15. doi: 10.1161/01.CIR.0000143144.82338.36. Epub 2004 Sep 27.
3
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).ST段抬高型急性心肌梗死溶栓后广泛应用经皮冠状动脉介入治疗与直接经皮冠状动脉介入治疗的比较:来自法国急性ST段抬高型心肌梗死注册研究(FAST-MI)的数据
Circulation. 2008 Jul 15;118(3):268-76. doi: 10.1161/CIRCULATIONAHA.107.762765. Epub 2008 Jun 30.
4
Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).ST段抬高型心肌梗死患者早期再灌注治疗的临床获益情况(该情况通常被排除在随机临床试验之外)(来自急性心肌梗死最大个体化治疗加量试验[MITRA Plus]注册研究的结果)
Am J Cardiol. 2009 Oct 15;104(8):1074-7. doi: 10.1016/j.amjcard.2009.05.054.
5
[Two year follow-up of acute ischemic syndrome without ST elevation].无ST段抬高急性缺血综合征的两年随访
Zhonghua Yi Xue Za Zhi. 2005 Jan 19;85(3):184-8.
6
Acute coronary syndrome in young adults: the Thai ACS Registry.年轻成年人急性冠状动脉综合征:泰国急性冠状动脉综合征注册研究
J Med Assoc Thai. 2007 Oct;90 Suppl 1:81-90.
7
[Reduction in acute myocardial infarction mortality over a five-year period].五年期间急性心肌梗死死亡率的降低
Rev Esp Cardiol. 2006 Mar;59(3):200-8.
8
Gender-related risk factors and outcomes for non-Q wave myocardial infarction patients receiving in-hospital PTCA.接受住院期间经皮冠状动脉腔内血管成形术(PTCA)的非Q波心肌梗死患者的性别相关危险因素及预后
J Invasive Cardiol. 1999 Mar;11(3):121-6.
9
The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.捷克共和国不同医院类型“再灌注网络”中急性冠脉综合征的发病率、治疗策略及转归:捷克住院患者急性冠脉综合征评估(CZECH)注册研究结果
Int J Cardiol. 2007 Jul 10;119(2):212-9. doi: 10.1016/j.ijcard.2007.02.036. Epub 2007 Apr 18.
10
Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).首次心肌梗死患者中与ST段抬高型心肌梗死相关的药物治疗:瑞典心脏重症监护入院信息与知识登记册(RIKS-HIA)
Arch Intern Med. 2010 Aug 9;170(15):1375-81. doi: 10.1001/archinternmed.2010.203.

引用本文的文献

1
Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study.法国ST段抬高型心肌梗死(STEMI)后心脏康复及治疗依从性的影响:STOP SCA+研究
Front Cardiovasc Med. 2025 Jun 12;12:1484401. doi: 10.3389/fcvm.2025.1484401. eCollection 2025.
2
Improving STEMI Management Internationally: Initial Report of the American College of Cardiology-Global Heart Attack Treatment Initiative.在国际上改善ST段抬高型心肌梗死的管理:美国心脏病学会-全球心脏病发作治疗倡议的初步报告
JACC Adv. 2024 Dec 10;4(1):101438. doi: 10.1016/j.jacadv.2024.101438. eCollection 2025 Jan.
3
Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality.
急性心肌梗死中的2型糖尿病:对长期死亡率持续存在的重大负担。
Front Cardiovasc Med. 2024 Jun 12;11:1401569. doi: 10.3389/fcvm.2024.1401569. eCollection 2024.
4
Comparison of Real-Life Systems of Care for ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死真实护理系统的比较
Glob Heart. 2020 Oct 1;15(1):66. doi: 10.5334/gh.343.
5
Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice?REDUCE-IT 试验对 FAST-MI 登记研究的适用性。随机试验的结果在常规临床实践中是否相关?
Clin Cardiol. 2020 Nov;43(11):1260-1265. doi: 10.1002/clc.23437. Epub 2020 Jul 28.
6
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.因子 V Leiden 与随后的动脉粥样血栓事件的关联:个体参与者数据的 GENIUS-CHD 研究。
Circulation. 2020 Aug 11;142(6):546-555. doi: 10.1161/CIRCULATIONAHA.119.045526. Epub 2020 Jul 13.
7
Current status of acute myocardial infarction in Korea.韩国急性心肌梗死的现状。
Korean J Intern Med. 2019 Jan;34(1):1-10. doi: 10.3904/kjim.2018.381. Epub 2018 Dec 28.
8
Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.急性心肌梗死后的动脉粥样硬化血栓形成风险分层:鉴于法国急性ST段抬高或非ST段抬高型心肌梗死注册研究,心肌梗死溶栓治疗二级预防风险评分。
Clin Cardiol. 2019 Feb;42(2):227-234. doi: 10.1002/clc.23131. Epub 2018 Dec 27.
9
Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach.通过直接经皮冠状动脉介入治疗(primary PCI)或药物介入治疗方法,对ST段抬高型心肌梗死(STEMI)患者进行早期和晚期再灌注时采用经桡动脉途径。
Egypt Heart J. 2018 Mar;70(1):1-7. doi: 10.1016/j.ehj.2017.04.001. Epub 2017 Jun 12.
10
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.β受体阻滞剂与无心力衰竭心肌梗死患者的死亡率:多中心前瞻性队列研究
BMJ. 2016 Sep 20;354:i4801. doi: 10.1136/bmj.i4801.